Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer
Condition(s):Recurrent Head and Neck CancerLast Updated:August 31, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Recurrent Head and Neck CancerLast Updated:August 31, 2023Recruiting
Condition(s):Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma PatientsLast Updated:September 14, 2016Completed
Condition(s):Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic SyndromesLast Updated:March 9, 2022Terminated
Condition(s):LeukemiaLast Updated:December 11, 2023Active, not recruiting
Condition(s):Hematologic Malignancies; Nonmalignant Diseases; Immunodeficiencies; Hemoglobinopathies; Genetic Inborn Errors of Metabolism; Fanconi Anemia; Thalassemia; Sickle Cell DiseaseLast Updated:October 4, 2021Completed
Condition(s):LeukemiaLast Updated:September 25, 2019Completed
Condition(s):Head and Neck CancerLast Updated:June 10, 2015Completed
Condition(s):LymphomaLast Updated:June 28, 2012Terminated
Condition(s):Acute Myeloid Leukemia; AML1-ETO Fusion Protein ExpressionLast Updated:December 31, 2013Unknown status
Condition(s):Primary Central Nervous System LymphomaLast Updated:February 29, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.